Cellebrite
CLBT
CLBT
116 hedge funds and large institutions have $780M invested in Cellebrite in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 18 reducing their positions, and 12 closing their positions.
Holders
116
Holders Change
+22
Holders Change %
+23.4%
% of All Funds
1.7%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
34
Increased
49
Reduced
18
Closed
12
Calls
$650K
Puts
$23K
Net Calls
+$627K
Net Calls Change
+$135K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$62.5M |
| 2 |
NTCM
2
Nine Ten Capital Management
Chicago,
Illinois
|
$32.1M |
| 3 |
ACM
3
Ashford Capital Management
Wilmington,
Delaware
|
$12.9M |
| 4 |
VC
4
Voss Capital
Houston,
Texas
|
$15.9M |
| 5 |
5
Two Sigma Investments
New York
|
$11.2M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GI
126
Gradient Investments
Arden Hills,
Minnesota
| – | – | -2,400 | Closed |
|
127
First Manhattan
New York
| – | – | -37 | Closed |
|
128
Fidelity Investments
Boston,
Massachusetts
| – | – | -2 | Closed |
|
|
CFGS
129
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
130
Alyeska Investment Group
Chicago,
Illinois
| – | – | – | – |
|